Overall, our study delivers a new conceptual framework for RIG‐I function in cancer, thus setting the stage for future mechanistic (preclinical) and prospective (clinical) work addressing and tackling RIG‐I‐associated immunosuppression. This evidence concerns the gene RIGI and cancer.